Cassava Sciences, Inc. FLNA
0.75
(0.02)
(2.60%)
as of 25 Sep
- Market cap
- $37.8M
- P/E
- 0.0×
Follow FLNA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
2.27 | 2.23 | 2.19 | 2.08 |
Net Debt/EBITDA |
9.04 | 7.24 | 7.92 | 9.04 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.58 | 0.78 | 0.86 | 0.45 | |
Capex/Depreciation |
(0.61) | (1.37) | 0.00 | (0.09) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.13) | (0.21) | (0.18) | (0.08) | |
Cash per Share |
2.20 | 1.98 | 1.79 | 1.71 | |
Shareholders Equity per Share |
1.69 | 1.54 | 1.41 | 1.32 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.69 | 1.54 | 1.41 | 1.32 | |
Free Cash Flow |
(6.30) | (10.25) | (8.88) | (3.88) | |
Working Capital |
60.86 | 53.88 | 47.85 | 43.57 | |
Capital Expenditures |
(0.08) | (0.50) | — | (0.02) | |
Net Current Asset Value |
60.75 | 53.76 | 47.74 | 43.43 | |
| Other line items | |||||
Quick Ratio |
2.21 | 2.18 | 2.16 | 2.06 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.13) | (0.20) | (0.18) | (0.08) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Average Payables |
49.17 | 24.65 | 23.69 | 41.06 | |
Average Assets |
176.74 | 137.94 | 124.65 | 119.64 | |
Average Common Equity |
124.10 | 110.05 | 97.88 | 75.79 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates